Key result
Sarcomere mutations in HCM linked to ~481% greater odds of midepicardial fibrosis and impaired strain.
Why the study?
Myocyte disarray and fibrosis underlie hypertrophic cardiomyopathy caused by genetic mutations, but the extent of their contributions has not been extensively evaluated.
Does the presence of sarcomere-associated mutations affect left ventricular myocardial mechanics and fibrosis patterns in patients with hypertrophic cardiomyopathy?
Cross-Sectional (n=133)
Yes
Does the presence of sarcomere-associated mutations affect left ventricular myocardial mechanics and fibrosis patterns in patients with hypertrophic cardiomyopathy?
Effect estimate: OR 5.81 (95% CI 2.15-15.72)
Absolute Event Rate: 82.9% vs 42.4%
p-value: p=0.001
In patients with hypertrophic cardiomyopathy, sarcomere-associated mutations are independently associated with impaired circumferential fiber function and midepicardial fibrosis.
May inform fibrosis risk assessment in HCM; leaves open prospective validation for genotype-guided management.
Myocyte disarray and fibrosis are underlying pathologies of hypertrophic cardiomyopathy (HCM) caused by genetic mutations. However, the extent of their contributions has not been extensively evaluated. In this study, we investigated the effects of genetic mutations on myofiber function and fibrosis patterns in HCM. A total of 133 patients with HCM underwent chamber geometry, late gadolinium enhancement (LGE), and T1-mapping evaluation using 1.5T cardiac magnetic resonance (CMR) imaging, echo-derived diastolic function analyses, and genetic testing. Left ventricular (LV) segmental and global longitudinal strain (LS), circumferential strain (CS), and rotation were measured using feature tracking analysis. Patients with sarcomere-associated mutation (SM, n = 41) exhibited lower LV-CS (all three slices) and higher basal rotationendo, along with a higher prevalence of midepicardial LGE. The relationship between SM and LV-CSmyo was independent of LGE amount (ß = 0.239, p = 0.008). However, global LS and E/e’ were not correlated with SM but were associated with LV mass index and LGE extent. SM was significantly correlated with the presence of midepicardial LGE (odds ratio 5.81, 95% confidence interval 2.15–15.72, p = 0.001), independent of LV mass index, hypertrophy pattern and E/e’. Augmented LV basal segmental rotation was significantly associated with dynamic obstruction. Circumferential fiber dysfunction and midepicardial fibrosis were related to SM, independent of the extent of LV hypertrophy. However, longitudinal fiber function was correlated to the extent of hypertrophy and fibrosis, regardless of SM. Subendocardial fibrosis did not show a significant association with SM.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) conducted a cross-sectional in Hypertrophic cardiomyopathy (n=133). Sarcomere-associated mutation vs. No sarcomere-associated mutation was evaluated on Presence of midepicardial late gadolinium enhancement (OR 5.81, 95% CI 2.15-15.72, p=0.001). In patients with hypertrophic cardiomyopathy, sarcomere-associated mutations were significantly associated with the presence of midepicardial fibrosis (OR 5.81) and impaired circumferential strain.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: